How Increasing Prevalence of Chronic Diseases are Positively Impacted on Hypodermic Needle Market
The hypodermic needle is a void needle usually used with a syringe to inject substances into the body or extract fluids from the body.
Choose which categories of cookies you allow. Strictly necessary cookies are always on.
Required for core site functionality, security and your session. Always active.
Help us understand how visitors use the site (e.g. Google Analytics) so we can improve it.
Used to measure campaigns and show you relevant ads on other sites (e.g. LinkedIn, Google Ads).
Hypodermic Needles Market Analysis size 2021 was recorded $3,429.89 Million whereas by the end of 2026 it will reach $4026.80 Million. According to the author, by 2033 Hypodermic Needles market size will become $5,042.75 Million. Hypodermic Needles market will be growing at a CAGR of 3.264% during 2026 to 2033. Download a free sample with data verified by Supriya Yadav
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Products Segment | Safety Hypodermic Needles, Non-safety Hypodermic Needles |
| Application Segment | Drug Delivery, Vaccination, Blood Specimen Collection |
| End users Segment | Hospital, Diabetic Patients, Family Practitioners, Psychiatry, Others |
|---|---|
| Regions & Countries |
|
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global | $ 3429.89 Million | $ 3900.1 Million | $ 5042.75 Million | 3.264% |
| North America | $ 990.9 Million | $ 1114.65 Million | $ 1386.25 Million | 2.763% |
| United States | $ 780.53 Million | $ 876.92 Million | $ 1071.88 Million | 2.541% |
| Canada | $ 122.08 Million | $ 136.23 Million | $ 184.12 Million | 3.837% |
| Mexico | $ 88.29 Million | $ 101.5 Million | $ 130.25 Million | 3.167% |
| Europe | $ 641.39 Million | $ 720.74 Million | $ 892.06 Million | 2.702% |
| United Kingdom | $ 81.33 Million | $ 90.75 Million | $ 105.18 Million | 1.862% |
| France | $ 84.15 Million | $ 94.99 Million | $ 124.7 Million | 3.461% |
| Germany | $ 96.72 Million | $ 108.12 Million | $ 127.57 Million | 2.09% |
| Italy | $ 46.44 Million | $ 52.46 Million | $ 66.99 Million | 3.102% |
| Russia | $ 69.91 Million | $ 78.26 Million | $ 91.78 Million | 2.012% |
| Spain | $ 50.67 Million | $ 56.64 Million | $ 65.01 Million | 1.739% |
| Sweden | $ 20.2 Million | $ 22.47 Million | $ 24.43 Million | 1.047% |
| Denmark | $ 14.37 Million | $ 15.84 Million | $ 18.11 Million | 1.692% |
| Switzerland | $ 12.64 Million | $ 13.89 Million | $ 15.14 Million | 1.083% |
| Luxembourg | $ 10.46 Million | $ 11.44 Million | $ 13 Million | 1.61% |
| Rest of Europe | $ 154.51 Million | $ 175.9 Million | $ 240.16 Million | 3.969% |
| Asia Pacific | $ 1365.1 Million | $ 1564.72 Million | $ 2118.46 Million | 3.86% |
| China | $ 402.57 Million | $ 460.03 Million | $ 602.28 Million | 3.425% |
| Japan | $ 274.52 Million | $ 313.57 Million | $ 410.35 Million | 3.419% |
| South Korea | $ 103.47 Million | $ 117.2 Million | $ 144.69 Million | 2.669% |
| India | $ 192.89 Million | $ 223.13 Million | $ 320.31 Million | 4.623% |
| Australia | $ 39.04 Million | $ 43.34 Million | $ 48.94 Million | 1.529% |
| Singapore | $ 50.1 Million | $ 58.83 Million | $ 83.04 Million | 4.402% |
| Taiwan | $ 21.71 Million | $ 23.63 Million | $ 28.6 Million | 2.416% |
| South East Asia | $ 126.82 Million | $ 146.46 Million | $ 203.8 Million | 4.216% |
| Rest of APAC | $ 153.98 Million | $ 178.54 Million | $ 276.46 Million | 5.618% |
| South America | $ 233.23 Million | $ 277.69 Million | $ 388.8 Million | 4.297% |
| Brazil | $ 73.84 Million | $ 87.78 Million | $ 119.6 Million | 3.942% |
| Argentina | $ 30.74 Million | $ 36.71 Million | $ 53.53 Million | 4.83% |
| Colombia | $ 19.64 Million | $ 23.3 Million | $ 31.27 Million | 3.743% |
| Peru | $ 10.87 Million | $ 12.87 Million | $ 17.01 Million | 3.547% |
| Chile | $ 5.08 Million | $ 6.02 Million | $ 7.8 Million | 3.301% |
| Rest of South America | $ 93.06 Million | $ 111.01 Million | $ 159.59 Million | 4.642% |
| Middle East | $ 123.48 Million | $ 127.92 Million | $ 145.74 Million | 1.643% |
| Saudi Arabia | $ 44.95 Million | $ 46.35 Million | $ 51.65 Million | 1.363% |
| Turkey | $ 15.32 Million | $ 15.74 Million | $ 17.21 Million | 1.128% |
| UAE | $ 12.01 Million | $ 12.6 Million | $ 15.65 Million | 2.748% |
| Egypt | $ 10.76 Million | $ 11.26 Million | $ 13.39 Million | 2.195% |
| Qatar | $ 9.79 Million | $ 9.99 Million | $ 10.95 Million | 1.146% |
| Rest of Middle East | $ 30.65 Million | $ 31.99 Million | $ 36.89 Million | 1.794% |
| Africa | $ 75.8 Million | $ 94.38 Million | $ 111.45 Million | 2.099% |
| East Africa | xxxx | xxxx | xxxx | xxxx |
| West Africa | xxxx | xxxx | xxxx | xxxx |
| North Africa | xxxx | xxxx | xxxx | xxxx |
| South Africa | $ 25.29 Million | $ 31.4 Million | $ 36.12 Million | 1.765% |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Hypodermic Needles Market Products Segment Analysis According to Cognitive Market Research, the safety hypodermic needles segment stands as the dominant category within the hypodermic needles market. This dominance is attributed to the increasing emphasis on needle safety in both healthcare settings and home care environments. Safety hypodermic needles are designed to prevent needle-stick injuries, which are a significant concern for healthcare professionals due to the risk of transmitting infections. The non-safety hypodermic needles segment is currently experiencing the fastest growth within the market. This surge is driven by the increasing adoption of non-safety needles in research and specialized medical procedures where safety features are less critical compared to cost-effectiveness and precision. Non-safety hypodermic needles are favored for their lower cost and are widely used in diagnostic and laboratory applications.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
The Hypodermic Needles Market is highly competitive, with several established players and emerging companies striving for market share through product innovation, pricing strategies, and geographic expansion. Leading players such as Becton, Dickinson and Company (BD), Terumo Corporation, and Smiths Medical dominate the market due to their extensive product portfolios, global distribution networks, and ongoing investments in safety-engineered needle technology.
In February 2023, Tarkett has collaborated with Dutch design research firm Studio RENS, to launch DESSO X RENS, a range of carpet tiles that can be recycled into a new raw material. (Source: https://www.tarkett-group.com/en/recycling-carpet/) In November 2022, Mohawk Industries, Inc. acquired Elizabeth Coatings (Brazil). With this acquisition, the company became the largest producer of ceramic tiles by revenue in Brazil. (Source: https://www.eliane.com/blog/mohawk-industries-anuncia-a-aquisicao-de-elizabeth-revestimentos-no-brasil?lang=en)
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Tarkett SA | ••• | ••• | ••• | ••• |
| Mohawk Industries Inc. | ••• | ••• | ••• | ••• |
| Shaw Industries Group Inc. | ••• | ••• | ••• | ••• |
| Armstrong Flooring Inc. | ••• | ••• | ••• | ••• |
| Beaulieu International Group | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →The global hypodermic needles market is poised for steady expansion, projected to grow from USD 3,429.89 million in 2021 to USD 5,042.75 million by 2033, reflecting a compound annual growth rate (CAGR) of 3.264%. This growth is primarily fueled by the rising prevalence of chronic diseases such as diabetes, which require regular injections for management, and the increasing volume of vaccination and immunization programs worldwide. Technological advancements, particularly the development and adoption of safety-engineered needles designed to prevent needlestick injuries, are significantly shaping market trends. The market is also driven by a growing patient population and expanding healthcare infrastructure, especially in emerging economies. Asia-Pacific currently dominates the market, with North America following closely. The ongoing shift towards home healthcare and self-administration of medications further contributes to the demand for user-friendly and safe hypodermic needles.
Manufacturers should prioritize investment in the research and development of advanced safety needles and pain-reduction technologies to meet regulatory demands and enhance patient satisfaction. Expanding market presence in high-growth regions like Asia-Pacific and South America through strategic partnerships and localized distribution networks is critical for long-term growth. Furthermore, focusing on sustainable manufacturing practices and developing eco-friendly disposal solutions can provide a competitive edge and appeal to environmentally conscious healthcare providers.
Hypodermic needles are thin, hollow tubes used in medical applications to inject or withdraw fluids, commonly paired with syringes for delivering medications, vaccines, and drawing blood. These needles are essential tools in both routine healthcare practices and specialized treatments, offering precision in drug delivery, blood sampling, and intravenous administration. The Hypodermic Needles Market has witnessed significant growth, driven by the rising prevalence of chronic diseases like diabetes, cancer, and autoimmune disorders, which require frequent injectable therapies. Additionally, the expansion of global vaccination programs and advancements in needle technology, such as safety-engineered needles designed to reduce needlestick injuries, have further propelled market demand.
In June 2023, Unilin Technologies and Mohawk Industries signed the digital printing licensing contract with Swiss Krono, a leading global manufacturer of innovative flooring solutions. (Source: https://www.unilintechnologies.com/en/news/unilin-technologies-enters-licensing-contract-swiss-krono-digital-printing-laminate-flooring)
As per Cognitive's Research Analyst, Hypodermic Needles are an essential segment of the medical devices industry. They play an essential role in drug delivery, vaccination, and blood sample collection for various medical applications.
Looking at the Historical Growth The global market expanded from $3,429.89 million in 2021 to an estimated $4026.80 million in 2026 due to the rising prevalence of chronic diseases requiring regular injections and increasing volume of vaccination programs worldwide. Regionally, Asia Pacific grew from $1365.1 million in 2021 to $1625.11 million in 2026, while North America progressed from $990.895 million to $1145.47 million over the same period.
Currently in 2026, Asia Pacific holds a commanding 40.36% of the global market, driven by large patient populations, significant healthcare expenditure, and growth in medical tourism. The drug delivery and vaccination programs segment remains the primary consumer of Hypodermic Needles. Additionally South America is set to be the fastest-growing region, exhibiting the highest CAGR of 4.297%, fueled by expanding public healthcare coverage and increasing awareness of disease prevention.
The market is witnessing a definitive shift towards safety-engineered needles, driven by the need to mitigate the risk of needlestick injuries and the transmission of bloodborne pathogens. Ongoing innovation in patient comfort technologies is also leading, focusing on ultra-fine gauge needles and advanced tip geometries to minimize pain.
In the future, The global Hypodermic Needles market will reach to $5,042.75 million by 2033, expanding at a compound annual growth rate of 3.264% from 2021, primarily driven by expanding healthcare infrastructure, a growing patient population, and continued technological advancements in safety-engineered needles. Ongoing innovation in patient comfort solutions and the strong trend towards increased self-administration of medications will also contribute significantly.
★ Reviews
Rate this report
| Products | Safety Hypodermic Needles, Non-safety Hypodermic Needles |
|---|---|
| Application | Drug Delivery, Vaccination, Blood Specimen Collection |
| End users | Hospital, Diabetic Patients, Family Practitioners, Psychiatry, Others |
| List of Competitors | Tarkett SA, Mohawk Industries Inc., Shaw Industries Group Inc., Armstrong Flooring Inc., Beaulieu International Group |
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Hypodermic Needles Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
The hypodermic needle is a void needle usually used with a syringe to inject substances into the body or extract fluids from the body.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Hypodermic Needles Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the hypodermic needles market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.